Has TB CARE I sputum transport improved access to culture services for retreatment tuberculosis patients in Zimbabwe?

about

Has TB CARE I sputum transport improved access to culture services for retreatment tuberculosis patients in Zimbabwe?

Item

http://www.wikidata.org/entity/Q55343656

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Has TB CARE I sputum transport ...... rculosis patients in Zimbabwe?

@en

Has TB CARE I sputum transport ...... rculosis patients in Zimbabwe?

@nl

type

Item

label

Has TB CARE I sputum transport ...... rculosis patients in Zimbabwe?

@en

Has TB CARE I sputum transport ...... rculosis patients in Zimbabwe?

@nl

prefLabel

Has TB CARE I sputum transport ...... rculosis patients in Zimbabwe?

@en

Has TB CARE I sputum transport ...... rculosis patients in Zimbabwe?

@nl

P1476

Has TB CARE I sputum transport ...... rculosis patients in Zimbabwe?

@en

P2093

A D Harries

http://www.w3.org/2001/XMLSchema#string

A M V Kumar

http://www.w3.org/2001/XMLSchema#string

C Sandy

http://www.w3.org/2001/XMLSchema#string

C Zishiri

http://www.w3.org/2001/XMLSchema#string

K C Takarinda

http://www.w3.org/2001/XMLSchema#string

P2860

Impact of Xpert MTB/RIF for TB diagnosis in a primary care clinic with high TB and HIV prevalence in South Africa: a pragmatic randomised trial

Effect of Introducing Xpert MTB/RIF to Test and Treat Individuals at Risk of Multidrug-Resistant Tuberculosis in Kazakhstan: A Prospective Cohort Study

Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study

Rapid molecular detection of tuberculosis and rifampin resistance

Are sputum samples of retreatment tuberculosis reaching the reference laboratories? A 9-year audit in Tanzania.

Screening retreatment tuberculosis patients for drug resistance in mid-west Nepal: how well are we doing?

Diagnosis and treatment of TB patients with rifampicin resistance detected using Xpert(®) MTB/RIF in Zimbabwe.

Feasibility, accuracy, and clinical effect of point-of-care Xpert MTB/RIF testing for tuberculosis in primary-care settings in Africa: a multicentre, randomised, controlled trial.

Evaluation of a Rapid Molecular Drug-Susceptibility Test for Tuberculosis.

Isoniazid-monoresistant tuberculosis is associated with poor treatment outcomes in Durban, South Africa.

P304

66-71

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5588/PHA.17.0117

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

C Timire

P577

2018-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29946522

http://www.w3.org/2001/XMLSchema#string

P921

sputum

P932

6012960

http://www.w3.org/2001/XMLSchema#string